Long-Term Analysis of an Open-Label, Multicentre, Randomized Phase 3 Trial Comparing Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine As a Preparative Regimen for Allogeneic Stem-Cell Transplantation in Patients with Acute Myeloid Leukemia

Autor:	Cavallaro, Gianluca *, Grassi, Anna *, Pavoni, Chiara *, Mico', Maria Caterina *, Busca, Alessandro *, Cavattoni, Irene Maria *, Santarone, Stella, Borghero, Carlo *, Olivieri, Attilio *, Milone, Giuseppe, Chiusolo, Patrizia *, Musto, Pellegrino, Saccardi, Riccardo, Patriarca, Francesca *, Pane, Fabrizio, Saporiti, Giorgia *, Rivela, Paolo *, Terruzzi, Elisabetta *, Cerretti, Raffaella *, Marotta, Giuseppe *, Carella, Angelo Michele *, Nagler, Arnon, Russo, Domenico, Corradini, Paolo, Bernasconi, Paolo, Iori, Anna Paola *, Castagna, Luca *, Mordini, Nicola *, Oldani, Elena *, Di Grazia, Carmen *, Bacigalupo, Andrea, Rambaldi, Alessandro
Zdroj:	In Blood 15 November 2022 140 Supplement 1:7667-7669
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu